Your browser doesn't support javascript.
loading
CD8+ T cells inhibit metastasis and CXCL4 regulates its function.
Joseph, Robiya; Soundararajan, Rama; Vasaikar, Suhas; Yang, Fei; Allton, Kendra L; Tian, Lin; den Hollander, Petra; Isgandarova, Sevinj; Haemmerle, Monika; Mino, Barbara; Zhou, Tieling; Shin, Crystal; Martinez-Paniagua, Melisa; Sahin, Aysegul A; Rodriguez-Canales, Jaime; Gelovani, Juri; Chang, Jeffrey T; Acharya, Ghanashyam; Sood, Anil K; Wistuba, Ignacio I; Gibbons, Don L; Solis, Luisa M; Barton, Michelle C; Varadarajan, Navin; Rosen, Jeffrey M; Zhang, Xiang H; Mani, Sendurai A.
Afiliação
  • Joseph R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Soundararajan R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vasaikar S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yang F; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Allton KL; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tian L; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
  • den Hollander P; Sloan Kettering Institute, New York, NY, USA.
  • Isgandarova S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Haemmerle M; Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX, USA.
  • Mino B; Department of Gynecologic Oncology and Reproductive Medicine and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhou T; University Clinic Halle, Institute of Pathology, Halle, Germany.
  • Shin C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Martinez-Paniagua M; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sahin AA; Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
  • Rodriguez-Canales J; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX, USA.
  • Gelovani J; Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chang JT; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Acharya G; AstraZeneca, Gaithersburg, MD, USA.
  • Sood AK; Department of Experimental Diagnostic Imaging, Wayne State University, Detroit, MI, USA.
  • Wistuba II; Department of Integrative Biology and Pharmacology, UT Health Sciences Center at Houston, Houston, TX, USA.
  • Gibbons DL; Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
  • Solis LM; Department of Gynecologic Oncology and Reproductive Medicine and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Barton MC; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Varadarajan N; Department of Thoracic Head and Neck Medical Oncology, Division of Cancer Medicine Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rosen JM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang XH; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mani SA; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX, USA.
Br J Cancer ; 125(2): 176-189, 2021 07.
Article em En | MEDLINE | ID: mdl-33795809

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Fator Plaquetário 4 / Antígenos CD4 / Antígenos CD8 / Linfócitos T CD8-Positivos / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Fator Plaquetário 4 / Antígenos CD4 / Antígenos CD8 / Linfócitos T CD8-Positivos / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos